BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27354894)

  • 1. Incidence and trends of cardiovascular mortality after common cancers in young adults: Analysis of surveillance, epidemiology and end-results program.
    Al-Kindi SG; Oliveira GH
    World J Cardiol; 2016 Jun; 8(6):368-74. PubMed ID: 27354894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
    Al-Kindi SG; Abu-Zeinah GF; Kim CH; Hejjaji V; William BM; Caimi PF; Oliveira GH
    Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):748-52. PubMed ID: 26324747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial.
    Butler SS; Mahal BA; Moslehi JJ; Nohria A; Dee EC; Makkar R; Whitbeck A; Wangoe J; Mouw KW; Nguyen PL; Muralidhar V
    Cancer; 2021 Jul; 127(13):2213-2221. PubMed ID: 33905530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular-specific mortality among multiple myeloma patients: a population-based study.
    Yin X; Fan F; Zhang B; Hu Y; Sun C
    Ther Adv Hematol; 2022; 13():20406207221086755. PubMed ID: 35387110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
    Voog JC; Paulus R; Shipley WU; Smith MR; McGowan DG; Jones CU; Bahary JP; Zeitzer KL; Souhami L; Leibenhaut MH; Rotman M; Husain SM; Gore E; Raben A; Chafe S; Sandler HM; Efstathiou JA
    Eur Urol; 2016 Feb; 69(2):204-10. PubMed ID: 26362090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular-Specific Mortality among Gastrointestinal Stromal Tumor Patients: A Population-Based Analysis.
    Yao H; Shi H; Fan M; Yuan L; Lin R
    Oxid Med Cell Longev; 2023; 2023():3619306. PubMed ID: 36825080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Cardiovascular-Specific Mortality in Patients With Prostate Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Study.
    Alhadeethi A; Atia A; Alkhawaldeh IM; Ibrahim AA; Afifi E; Elwekel A; Nouh A; Morsi MH
    Cureus; 2023 Dec; 15(12):e51279. PubMed ID: 38288190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975-2016.
    Lewis DR; Siembida EJ; Seibel NL; Smith AW; Mariotto AB
    Cancer; 2021 Nov; 127(22):4277-4286. PubMed ID: 34308557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competing risk analysis of cardiovascular-specific mortality in typical carcinoid neoplasms of the lung: A SEER database analysis.
    Xing H; Wu C; Zhang D; Zhang X
    Medicine (Baltimore); 2023 Oct; 102(40):e35104. PubMed ID: 37800780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers.
    Cole AP; Lu C; Krimphove MJ; Szymaniak J; Sun M; Fletcher SA; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Haider AH; Trinh QD
    J Natl Compr Canc Netw; 2019 Sep; 17(9):1049-1058. PubMed ID: 31487683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of cerebrovascular mortality in head and neck cancer survivors aged ≥ 65 years treated with definitive radiotherapy: a population-based cohort study.
    He QS; Wang ZP; Li ZJ; Zhou P; Lian CL; Wu SG; Chen SF
    Radiat Oncol; 2021 Sep; 16(1):185. PubMed ID: 34544466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study.
    Zhao Y; Qin F; Ji Q; Xia W; He B
    Front Cardiovasc Med; 2022; 9():922811. PubMed ID: 36035954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992-1999.
    Paltoo DN; Chu KC
    Public Health Rep; 2004; 119(4):443-51. PubMed ID: 15219802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent cancer trends in the United States.
    Devesa SS; Blot WJ; Stone BJ; Miller BA; Tarone RE; Fraumeni JF
    J Natl Cancer Inst; 1995 Feb; 87(3):175-82. PubMed ID: 7707404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database.
    He J; Wang S; Liu H; Duan C; Zhang H; Wen F; Zhang C
    Transl Cancer Res; 2023 Dec; 12(12):3591-3603. PubMed ID: 38192997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases.
    Strongman H; Gadd S; Matthews A; Mansfield KE; Stanway S; Lyon AR; Dos-Santos-Silva I; Smeeth L; Bhaskaran K
    Lancet; 2019 Sep; 394(10203):1041-1054. PubMed ID: 31443926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report to the nation on the status of cancer, part 1: National cancer statistics.
    Cronin KA; Scott S; Firth AU; Sung H; Henley SJ; Sherman RL; Siegel RL; Anderson RN; Kohler BA; Benard VB; Negoita S; Wiggins C; Cance WG; Jemal A
    Cancer; 2022 Dec; 128(24):4251-4284. PubMed ID: 36301149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
    Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
    Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
    Sung H; Freedman RA; Siegel RL; Hyun N; DeSantis CE; Ruddy KJ; Jemal A
    Cancer; 2021 Sep; 127(18):3310-3324. PubMed ID: 34002851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.